Skip to main content
Caplight Logo









Bota Biosciences

Bota Biosciences

Private
HangzhouHealthcare & Life Scienceshttps://bota.bio/

Last Round

Series B

Jul 29, 2021

Total Funding Raised

$115M

Company Overview

Bota Biosciences is a biotechnology company that develops an industrial synthetic biology platform for the sustainable bio-manufacturing of high-performance ingredients and compounds.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Smart Manufacturing, Clean Manufacturing, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Infrastructure

Keywords

synthetic biologybiomanufacturingphysical aisynbiobiofoundrystrain engineeringai for sciencelab automationai-driven r&dbio-based manufacturingprocess developmentsustainable ingredientsbiotech platformsmart manufacturingcontract r&d

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bota Biosciences Comparables

Compare Bota Biosciences with similar companies based on industry and business-model similarity.

Bota Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tidetron Bioworks
79%
DataHow AG
78%
Abiochem Biotechnology
77%

Bota Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 29, 2021
StrategicMar 16, 2021
Series ASep 25, 2020

Key People

Founding team and executive leadership

Yi-Shu Tai

Chief Technology Officer

Executive Team

Bota Biosciences Investors

Notable investors and investment history

Bota Biosciences investors
InvestorRounds
MatrixSeries B, Series A
Nest.BioSeed
5Y CapitalSeries B
MPCSeries B, Series A
Source Code CapitalSeries B
Sherpa Healthcare PartnersSeries B, Series A
BASF Venture CapitalStrategic

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors grew 105% MoM, reaching 3.1K.

  • Mar 10, 2026

    Launched SAION AI, a Physical AI platform for biomanufacturing.

Bota Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bota Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bota Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Employee Range40
Year Founded2019
Last FundingJul 29, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?